[Risk of very preterm delivery: can we refrain from in utero transfer and manage these patients in level I and II maternity wards?].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005260:Female; D005602:France; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010360:Patient Transfer; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D015149:Tocolytic Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015149:Tocolytic Agents
Menace d'accouchement prématuré sévère précoce: est-il licite de ne pas transférer in utero et comment gérer une naissance en centre de niveau I et II?